Literature DB >> 29931722

Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora.

Aaron Pc Ong1,2, Nikki Angbue Te2, Sophia L Zagora1,2, Richard J Symes1,2, William Yates1,2, Andrew A Chang1,2, Peter J McCluskey1,2, Matthew P Simunovic1,2,3.   

Abstract

IMPORTANCE: Endophthalmitis is a serious complication of intraocular procedures: knowledge of its causative organisms and outcomes may guide prevention and treatment.
BACKGROUND: To determine the outcomes and spectrum of causative organisms in acute post-procedural endophthalmitis.
DESIGN: A retrospective observational case series performed at a tertiary referral hospital during the period 1 July 2012 to 31 July 2017. PARTICIPANTS: Two hundred and forty-eight patients diagnosed with acute (≤ 6 weeks post-inciting event) endophthalmitis.
METHODS: Chart review of microbiological and clinical data. MAIN OUTCOME MEASURES: The main outcome measure was odds of any improvement in visual acuity (3 months versus presentation). Secondary outcomes included causative organism, likelihood of vitrectomy and likelihood of evisceration.
RESULTS: One hundred and ninty cases were post-cataract surgery or post-intravitreal injection (49 and 141, respectively). Causative organisms were identified in 45% of post-cataract surgery and 54% of post-injection cases (OR = 0.69; P = 0.61). Staphylococcus epidermidis was the most frequent causative organism. Streptococcus species accounted for 32% of post-surgical and 7% of culture-positive post-injection cases (OR = 6.63; P = 0.02). At 3 months, 81% of post-surgical and 84% of post-injection cases had improved BCVA over presentation (OR 0.59; P = 0.61). CONCLUSIONS AND RELEVANCE: S. epidermidis is the most common causative organism. In contrast to other studies, we did not find evidence for an increased odds of Streptococcus spp. endophthalmitis following intravitreal injection. This may in turn reflect guideline-driven changes in practice.
© 2018 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  cataract surgery; endophthalmitis; infectious endophthalmitis; intravitreal injection

Mesh:

Substances:

Year:  2018        PMID: 29931722     DOI: 10.1111/ceo.13345

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  A Transcriptional Activator of Ascorbic Acid Transport in Streptococcus pneumoniae Is Required for Optimal Growth in Endophthalmitis in a Strain-Dependent Manner.

Authors:  Angela H Benton; Mary Darby Jackson; Sandy M Wong; Justine L Dees; Brian J Akerley; Mary E Marquart
Journal:  Microorganisms       Date:  2019-08-24

2.  Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes.

Authors:  Ana Maria Cunha; Maria Manuel Iglésias; Amândio Rocha-Sousa; Fernando Falcão-Reis; Manuel Falcão
Journal:  J Ophthalmol       Date:  2021-09-20       Impact factor: 1.909

3.  Near infra-red labelling and tracking of corneal endothelial cells in-vivo.

Authors:  Maninder Bhogal; Heng-Pei Ang; Shu-Jun Lin; Chan N Lwin; Khadijah Adnan; Gary Peh; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.379

4.  Validation of a multi-species-specific PCR panel to diagnose patients with suspected postoperative bacterial endophthalmitis.

Authors:  Justin van Halsema; Ruud Jansen; Adriaan Heineken; Tjaco M van Ossewaarde; Magda A Meester-Smoor; Jan C van Meurs
Journal:  Acta Ophthalmol       Date:  2021-07-13       Impact factor: 3.988

5.  Etiology, microbiological isolates, and antibiotic susceptibilities in culture-proven pediatric endophthalmitis: a 9-year review.

Authors:  Yao Yang; Lixia Lin; Yujie Li; Zhaoxin Jiang; Cheng Li; Manli Liu; Fang Duan; Xiaofeng Lin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-18       Impact factor: 3.117

Review 6.  Endophthalmitis: Changes in Presentation, Management and the Role of Early Vitrectomy.

Authors:  Emily H Shao; William B Yates; I-Van Ho; Andrew A Chang; Matthew P Simunovic
Journal:  Ophthalmol Ther       Date:  2021-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.